Faculty Opinions recommendation of Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.

Author(s):  
Carsten Bantel
2001 ◽  
Vol 5 (5) ◽  
pp. 409-416 ◽  
Author(s):  
Melody Vander Straten ◽  
Daniel Carrasco ◽  
Patricia Lee ◽  
Stephen K. Tyring

Background: Persons 50 years of age and older are not only at increased risk of developing herpes zoster, they are also more likely to suffer the long-term morbidity of postherpetic neuralgia (PHN). PHN is pain persisting after the rash of herpes zoster has healed. PHN affects at least 40% of all herpes zoster patients over age 50 and over 75% of herpes zoster patients over age 75; PHN is the single most common neurologic condition in elderly patients. Objective: The objective of this review is to evaluate interventions that may reduce or even eliminate PHN. No single therapy has been consistently effective for PHN. The most effective approach appears to be with the use of antiviral therapy early in the course of herpes zoster. The goals of ongoing studies in herpes zoster are to develop interventions that will further reduce the symptoms of PHN and/or to eliminate PHN by prophylaxis using the varicella vaccine. Conclusions: Reduction of PHN can best be achieved with the use of antiviral medication early in the course of herpes zoster; other classes of drugs are minimally effective in treating established PHN. Widespread use of the varicella vaccine may lead to secondary reductions in PHN in the distant future.


1999 ◽  
Vol 24 (4) ◽  
pp. 287-293
Author(s):  
Atsuhiro Kikuchi ◽  
Naoki Kotani ◽  
Tetsumi Sato ◽  
Kaori Takamura ◽  
Ichiro Sakai ◽  
...  

2020 ◽  
Vol 48 (12) ◽  
pp. 030006052097741
Author(s):  
Bei Wen ◽  
Yajie Wang ◽  
Cong Zhang ◽  
Weicheng Xu ◽  
Zhijian Fu

Objective We aimed to perform a network meta-analysis that combined both direct and indirect evidence to compare the relative efficacy of interventional therapies to treat patients with postherpetic neuralgia (PHN) and to determine the treatments’ superiority and validity. Method A conventional paired meta-analysis was performed. This was followed by a network meta-analysis using the Bayesian framework. Results Botulinum toxin type A and pulsed radiofrequency (PRF) were the two most effective individual interventions. For combination therapy, PRF + nerve block (NB) was the best choice, followed by subcutaneous injection or local infiltration (SC) + NB + ozone (O3). However, the combination of PRF + NB + SC showed reduced the efficacy compared with each treatment and was highly invasive for patients. After a long-term follow-up, PRF was shown to be the most effective therapy for treating patients with PHN. Conclusions Regular anti-neuropathic drug administration that was accompanied by interventional therapies at an early stage is the best choice to treat patients with PHN. Appropriate combinations of different interventions show improved pain relief. Clinicians should manage therapeutic regimens on the basis of the patients specific condition and existing measures and strive to achieve personalized treatment.


1991 ◽  
Vol 7 (1) ◽  
pp. 58
Author(s):  
CPN Watson ◽  
M. Chipman ◽  
R. J. Evans

1998 ◽  
Vol 89 (Supplement) ◽  
pp. 1076A
Author(s):  
A. Kikuchi ◽  
T. Sato ◽  
M. Kitayama ◽  
M. Asai ◽  
N. Kotani

Medicine ◽  
2020 ◽  
Vol 99 (36) ◽  
pp. e21976
Author(s):  
Jitsu Kato ◽  
Norimitsu Matsui ◽  
Yoshihiro Kakehi ◽  
Emiko Murayama ◽  
Shoichi Ohwada

Sign in / Sign up

Export Citation Format

Share Document